Publishes on Cardiac Valve Diseases and Treatments, Cardiac, Anesthesia and Surgical Outcomes, Coronary Interventions and Diagnostics. 240 papers and 127.8k citations.
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication.The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies.Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver.Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations.It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, \nwhether obstructive or non-obstructive. This process can be modified by lifestyle adjustments, pharmacological therapies, and invasive \ninterventions designed to achieve disease stabilization or regression. \nThe disease can have long, stable periods but can also become unstable at any time, typically due to an acute atherothrombotic event \ncaused by plaque rupture or erosion. However, the disease is \nchronic, most often progressive, and hence serious, even in clinically \napparently silent periods. The dynamic nature of the CAD process \nresults in various clinical presentations, which can be conveniently categorized as either acute coronary syndromes (ACS) or chronic \ncoronary syndromes (CCS). The Guidelines presented here refer to \nthe management of patients with CCS
The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS). \n \nDeveloped with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI).
Mathematical support for phonocardiographic signal processing has been developed based on a mathematical model in the form of a periodically correlated stochastic process and a component processing method. On the basis of mathematical support, algorithmic and software was developed in the Matlab environment for automated systems of computer diagnostics of the functional state of the valves of the human heart when mitral insufficiency is detected.
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.